Maares, M.* ; Haupt, A.* ; Schüßler, C.* ; Kulike-Koczula, M.* ; Hackler, J.* ; Keil, C.* ; Mohr, I.* ; Schomburg, L.* ; Süssmuth, R.D.* ; Zischka, H. ; Merle, U.* ; Haase, H.*
A fluorometric assay to determine labile copper(II) ions in serum.
Sci. Rep. 13:12807 (2023)
Labile copper(II) ions (Cu2+) in serum are considered to be readily available for cellular uptake and to constitute the biologically active Cu2+ species in the blood. It might also be suitable to reflect copper dyshomeostasis during diseases such as Wilson's disease (WD) or neurological disorders. So far, no direct quantification method has been described to determine this small Cu2+ subset. This study introduces a fluorometric high throughput assay using the novel Cu2+ binding fluoresceine-peptide sensor FP4 (Kd of the Cu2+-FP4-complex 0.38 pM) to determine labile Cu2+ in human and rat serum. Using 96 human serum samples, labile Cu2+was measured to be 0.14 ± 0.05 pM, showing no correlation with age or other serum trace elements. No sex-specific differences in labile Cu2+ concentrations were noted, in contrast to the total copper levels in serum. Analysis of the effect of drug therapy on labile Cu2+ in the sera of 19 patients with WD showed a significant decrease in labile Cu2+ following copper chelation therapy, suggesting that labile Cu2+ may be a specific marker of disease status and that the assay could be suitable for monitoring treatment progress.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Exchangeable Copper; Wilsons-disease; Reference Values; Plasma; Ceruloplasmin; Zinc; Quantification
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
2045-2322
e-ISSN
2045-2322
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 13,
Issue: 1,
Pages: ,
Article Number: 12807
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505200-003
Grants
r Promovierende)
Dahlem Research School (Elsa-Neumann-Stipendium fuuml
DFG
Deutsche Forschungsgemeinschaft (DFG), Research Unit FOR-2558 TraceAge-DFG Research Unit on Interactions of essential trace elements in healthy and diseased elderly, Potsdam-Berlin-Jena
Deutsche Forschungsgemeinschaft (DFG)
Copyright
Erfassungsdatum
2023-10-06